Information was received from a healthcare provider (hcp) and from a consumer via a manufacturer's representative (rep) regarding a patient who was receiving 15 mg/ml of fentanyl at 1.793 mg/day, 4 mg/ml of marcaine at 0.4782 mg/day, and 1.1 mg/ml of ketamine at 0.1315 mg/day via an implantable pump for other chronic/intractable pain (trunk/limbs) and spinal pain.On (b)(6) 2018, it was reported that the patient had an overdose.The patient reported that they fell on the morning of (b)(6) 2018 and was seen in the er.The patient stated that their feet were numb and they lost their balance.According to the patient, their feet frequently go numb and cause them to fall.At the er, the hcp reported that the patient was showing signs of overdose.A rep interrogated the patient's pump and found that it was working normally.No actions/interventions were taken to resolve the issue.No surgical intervention had occurred nor was a surgical intervention planned.The issue was considered resolved at the time of the report.No further complications were reported.The patient¿s medical history included seizure, high blood pressure, and chronic pain.
|